Autres langues Gentian Diagnostics

Actions

GENT

NO0010748866

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 06/05/2024			Varia. 5j.	Varia. 1 janv.
39,4 ^NOK	+2,07%		-1,01%	-5,06%

30/04	Gentian Diagnostics ASA annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
30/04	Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Presentation - Q1 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Report - Q1 2024	30/04
Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	29/04
Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	29/04
Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors	29/04
Gentian Diagnostics : Scientists to Gentian’s R&D department	08/04
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024	21/03
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024	21/03
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair	21/03
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	09/02
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors	18/12
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference	14/12
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
Gentian Diagnostics : Sales and Application Specialist - Nordic	10/10/23
Gentian Diagnostics ASA Expands Product Portfolio With Turbidimetric Retinol-Binding Protein Immunoassay	29/09/23
Gentian Diagnostics ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Gentian Diagnostics ASA (OB:GENT) acquired Getica Ab from Erling Sundrehagen for SEK 2.8 million.	03/07/23
Norway's Gentian Diagnostics Buys Sweden-based Getica in SEK3 Million Deal	15/06/23
Gentian Diagnostics ASA (OB:GENT) entered into an agreement to acquire Getica Ab from Erling Sundrehagen for SEK 3 million.	15/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Gentian Diagnostics

Actions

GENT

NO0010748866

Autres langues

Filtres